Better Therapeutics- Tradeable Rights - March 2021 Common Stock

As of the most recent data (September 2023), MCADR shows a common stock of $4K. That compares with $2K in the prior-year period — up 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MCADR's common stock is now $4K (was $2K) — a 100.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Better Therapeutics- Tradeable Rights - March 2021 is outperforming or lagging.

Tracking MCADR's common stock over time shows whether Better Therapeutics- Tradeable Rights - March 2021 is scaling, shrinking, or reshaping that part of the business. The current reading is $4K That compares with $2K in the prior-year period — up 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Better Therapeutics- Tradeable Rights - March 2021's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $4K) with ownership activity and broader fundamentals.